0001127602-20-015517.txt : 20200505 0001127602-20-015517.hdr.sgml : 20200505 20200505191208 ACCESSION NUMBER: 0001127602-20-015517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200505 FILED AS OF DATE: 20200505 DATE AS OF CHANGE: 20200505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thompson Tommy G CENTRAL INDEX KEY: 0001324863 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 20850627 MAIL ADDRESS: STREET 1: 7711 CARONDELET CITY: ST. LOUIS STATE: MO ZIP: 63105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-05-05 0001082554 UNITED THERAPEUTICS Corp UTHR 0001324863 Thompson Tommy G 1040 SPRING ST. SILVER SPRING MD 20910 1 Common Stock 2020-05-05 4 S 0 3100 112.555 D 14000 I By Family LLC Common Stock 9050 D This transaction was executed in multiple trades at prices ranging from $112.08 to $113.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares were transferred into a limited liability company beneficially owned by the reporting person on April 3, 2020. Shares were previously reported by the reporting person as directly owned. /s/ John S. Hess, Jr. under Power of Attorney 2020-05-05